Washed Microbiota Transplantation for Type 1 Diabetes Mellitus - Trial NCT06256614
Access comprehensive clinical trial information for NCT06256614 through Pure Global AI's free database. This phase not specified trial is sponsored by The Second Hospital of Nanjing Medical University and is currently Recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Second Hospital of Nanjing Medical University
Timeline & Enrollment
N/A
Mar 01, 2024
Jul 01, 2029
Primary Outcome
The Blood glucose of Time in Range (TIR, %) of type 1 diabetes mellitus.
Summary
This is a real-world study to explore the safety and the efficacy of washed microbiota
 transplantation (WMT) for patients with Type 1 Diabetes Mellitus (T1DM).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06256614
Non-Device Trial